Nutrien Stock Forecast, Price & News

Nutrien's stock was trading at $32.00 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, NTR stock has increased by 29.9% and is now trading at $41.57.
View which stocks have been most impacted by COVID-19.

21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 7 hold ratings, 13 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Nutrien.

Nutrien is scheduled to release its next quarterly earnings announcement on Monday, November 2nd 2020.
View our earnings forecast for Nutrien.

Nutrien will be holding an earnings conference call on Monday, November 2nd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Nutrien Ltd (NYSE:NTR) posted its quarterly earnings results on Monday, August, 10th. The company reported $1.45 earnings per share for the quarter, beating analysts' consensus estimates of $1.37 by $0.08. The firm earned $8.42 billion during the quarter, compared to analyst estimates of $8.32 billion. Nutrien had a net margin of 4.08% and a return on equity of 4.26%. The company's quarterly revenue was down 3.2% on a year-over-year basis. During the same period last year, the company posted $1.58 EPS.
View Nutrien's earnings history.

Nutrien declared a quarterly dividend on Monday, August 10th. Stockholders of record on Wednesday, September 30th will be paid a dividend of $0.45 per share on Friday, October 16th. This represents a $1.80 annualized dividend and a yield of 4.33%. The ex-dividend date of this dividend is Tuesday, September 29th.
View Nutrien's dividend history.

Nutrien updated its FY20 earnings guidance on Monday, August, 10th. The company provided earnings per share guidance of $1.50-1.90 for the period, compared to the Thomson Reuters consensus estimate of $1.62.

21 analysts have issued 1-year price targets for Nutrien's stock. Their forecasts range from $39.00 to $55.00. On average, they anticipate Nutrien's stock price to reach $46.29 in the next twelve months. This suggests a possible upside of 11.4% from the stock's current price.
View analysts' price targets for Nutrien.

Nutrien saw a increase in short interest in September. As of September 30th, there was short interest totaling 5,510,000 shares, an increase of 42.4% from the September 15th total of 3,870,000 shares. Based on an average trading volume of 1,590,000 shares, the short-interest ratio is currently 3.5 days. Currently, 1.0% of the company's stock are sold short.
View Nutrien's Short Interest.

Some companies that are related to Nutrien include The Scotts Miracle-Gro (SMG), The Mosaic (MOS), CF Industries (CF), ICL Group (ICL), American Vanguard (AVD), Bioceres Crop Solutions (BIOX), Bioceres Crop Solutions (BIOX), Marrone Bio Innovations (MBII), Calyxt (CLXT), CVR Partners (UAN), Evogene (EVGN), Wynnstay Group (WYN), Eden Research (EDEN), China Green Agriculture (CGA) and Bion Environmental Technologies (BNET).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), General Electric (GE), Intel (INTC), Bank of America (BAC), CVS Health (CVS), AbbVie (ABBV), JPMorgan Chase & Co. (JPM) and Micron Technology (MU).

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Nutrien's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include QV Investors Inc. (0.14%), PM CAPITAL Ltd (0.07%), Birch Hill Investment Advisors LLC (0.07%), Standard Life Aberdeen plc (0.06%), Hexavest Inc. (0.06%) and Sicart Associates LLC (0.06%).

NTR stock was sold by a variety of institutional investors in the last quarter, including Addenda Capital Inc., Hexavest Inc., Envestnet Asset Management Inc., QV Investors Inc., Livingston Group Asset Management CO operating as Southport Capital Management, Bruderman Asset Management LLC, Hennessy Advisors Inc., and Pinnacle Associates Ltd..

NTR stock was purchased by a variety of institutional investors in the last quarter, including PM CAPITAL Ltd, AMG National Trust Bank, Diversified Investment Strategies LLC, WealthTrust Axiom LLC, Pacifica Partners Inc., Great Valley Advisor Group Inc., Harbour Capital Advisors LLC, and Crossmark Global Holdings Inc..

Shares of NTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NTR stock can currently be purchased for approximately $41.57.

Nutrien has a market capitalization of $23.66 billion and generates $20.02 billion in revenue each year. The company earns $992 million in net income (profit) each year or $2.17 on an earnings per share basis. Nutrien employs 22,300 workers across the globe.

The official website for Nutrien is www.nutrien.com.

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The company can be reached via phone at 306-933-8500 or via email at [email protected]